PRELUDE CAPITAL MANAGEMENT, LLC - CAN-FITE BIOPHARMA LTD ownership

CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 7 filers reported holding CAN-FITE BIOPHARMA LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CAN-FITE BIOPHARMA LTD
ValueSharesWeighting
Q3 2017$2,000
+100.0%
1,200
+50.0%
0.00%
Q2 2017$1,000
-85.7%
800
-71.4%
0.00%
-100.0%
Q2 2016$7,0002,8000.00%
Other shareholders
CAN-FITE BIOPHARMA LTD shareholders Q3 2016
NameSharesValueWeighting ↓
TAYLOR ASSET MANAGEMENT INC 796,500$1,434,0000.48%
Psagot Value Holdings Ltd. 34,126$61,0000.00%
Virtu KCG Holdings LLC 21,565$39,0000.00%
MORGAN STANLEY 12,300$22,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 800$1,0000.00%
Citadel Advisors 16,738$30,0000.00%
RAYMOND JAMES & ASSOCIATES 12,200$22,0000.00%
View complete list of CAN-FITE BIOPHARMA LTD shareholders